Literature DB >> 9163627

Vaccination against influenza in multiple myeloma.

P Musto, M Carotenuto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9163627

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center.

Authors:  Petros D Grivas; Sumana Devata; Rami Khoriaty; Philip S Boonstra; Joshua Ruch; Kevin McDonnell; Leonel Hernandez-Aya; Joshua Wilfong; Jeffrey Smerage; Michael G Ison; Joseph N S Eisenberg; Maria Silveira; Kathleen A Cooney; Francis P Worden
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

2.  Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.

Authors:  Carlos G Grijalva; Yuwei Zhu; Derek J Williams; Wesley H Self; Krow Ampofo; Andrew T Pavia; Chris R Stockmann; Jonathan McCullers; Sandra R Arnold; Richard G Wunderink; Evan J Anderson; Stephen Lindstrom; Alicia M Fry; Ivo M Foppa; Lyn Finelli; Anna M Bramley; Seema Jain; Marie R Griffin; Kathryn M Edwards
Journal:  JAMA       Date:  2015-10-13       Impact factor: 56.272

3.  Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.

Authors:  Edward A Stadtmauer; Dan T Vogl; Eline Luning Prak; Jean Boyer; Nicole A Aqui; Aaron P Rapoport; Kenyetta R McDonald; Xiaoling Hou; Heather Murphy; Rita Bhagat; Patricia A Mangan; Anne Chew; Elizabeth A Veloso; Bruce L Levine; Robert H Vonderheide; Abbas F Jawad; Carl H June; Kathleen E Sullivan
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

4.  Adult Acute Myeloid Leukemia Long-term Survivors.

Authors:  M Jennifer Cheng; Christopher S Hourigan; Thomas J Smith
Journal:  J Leuk (Los Angel)       Date:  2014-04-10

Review 5.  Influenza vaccines for preventing cardiovascular disease.

Authors:  Christine Clar; Zainab Oseni; Nadine Flowers; Maryam Keshtkar-Jahromi; Karen Rees
Journal:  Cochrane Database Syst Rev       Date:  2015-05-05

6.  Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.

Authors:  J D Robertson; K Nagesh; S N Jowitt; M Dougal; H Anderson; K Mutton; M Zambon; J H Scarffe
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

Review 7.  Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).

Authors:  C T Rieger; B Liss; S Mellinghoff; D Buchheidt; O A Cornely; G Egerer; W J Heinz; M Hentrich; G Maschmeyer; K Mayer; M Sandherr; G Silling; A Ullmann; M J G T Vehreschild; M von Lilienfeld-Toal; H H Wolf; N Lehners
Journal:  Ann Oncol       Date:  2018-06-01       Impact factor: 32.976

Review 8.  Influenza vaccines in immunosuppressed adults with cancer.

Authors:  Roni Bitterman; Noa Eliakim-Raz; Inbal Vinograd; Anca Zalmanovici Trestioreanu; Leonard Leibovici; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

9. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513

10.  Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital.

Authors:  Benjamin W Teh; Leon J Worth; Simon J Harrison; Karin A Thursky; Monica A Slavin
Journal:  Support Care Cancer       Date:  2014-12-10       Impact factor: 3.603
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.